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ABSTRACT Efﬁcient screening technologies aim to reduce both the time and the cost
required for identifying rare mutants possessing a phenotype of interest in a mu-
tagenized population. In this study, we combined a mild mutagenesis strategy with
high-throughput screening based on microﬂuidic droplet technology to identify Lacto-
coccus lactis variants secreting vitamin B2 (riboﬂavin). Initially, we used a roseoﬂavin-
resistant mutant of L. lactis strain MG1363, JC017, which secreted low levels of riboﬂavin.
By using ﬂuorescence-activated droplet sorting, several mutants that secreted riboﬂavin
more efﬁciently than JC017 were readily isolated from the mutagenesis library. The
screening was highly efﬁcient, and candidates with as few as 1.6 mutations per million
base pairs (Mbp) were isolated. The genetic characterization revealed that riboﬂavin pro-
duction was triggered by mutations inhibiting purine biosynthesis, which is surprising
since the purine nucleotide GTP is a riboﬂavin precursor. Purine starvation in the
mutants induced overexpression of the riboﬂavin biosynthesis cluster ribABGH. When
the purine starvation was relieved by purine supplementation in the growth me-
dium, the outcome was an immediate downregulation of the riboﬂavin biosynthesis
cluster and a reduction in riboﬂavin production. Finally, by applying the new isolates
in milk fermentation, the riboﬂavin content of milk (0.99 mg/liter) was improved to
2.81 mg/liter, compared with 0.66 mg/liter and 1.51 mg/liter by using the wild-type
strain and the original roseoﬂavin-resistant mutant JC017, respectively. The results
obtained demonstrate how powerful classical mutagenesis can be when combined
with droplet-based microﬂuidic screening technology for obtaining microorganisms
with useful attributes.
IMPORTANCE The food industry prefers to use classical approaches, e.g., random
mutagenesis followed by screening, to improve microorganisms used in food pro-
duction, as the use of recombinant DNA technologies is still not widely accepted.
Although modern automated screening platforms are widely accessible, screen-
ing remains as a bottleneck in strain development, especially when a mild mu-
tagenesis approach is applied to reduce the chance of accumulating unintended
mutations, which may cause unwanted phenotypic changes. Here, we incorpo-
rate a droplet-based high-throughput screening method into the strain develop-
ment process and readily capture L. lactis variants with more efﬁcient vitamin se-
cretion from low-error-rate mutagenesis libraries. This study shows that useful
mutants showing strong phenotypes but without extensive mutations can be
identiﬁed with efﬁcient screening technologies. It is therefore possible to avoid
accumulating detrimental mutations while enriching beneﬁcial ones through iter-
ative mutagenesis screening. Due to the low mutation rates, the genetic deter-
minants are also readily identiﬁed.
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Random mutagenesis is a nondirected and powerful approach for obtaining usefulvariants of living organisms, including the less well-characterized ones. Random
mutagenesis is also valuable when the objective is to obtain cell factories with superior
performance, although research over the past two decades has rapidly expanded the
knowledge about metabolism and the development of genetic tools, enabling more
targeted optimization of cellular metabolism (1). Cellular metabolism is highly complex,
and it is difﬁcult to predict the consequences of a particular perturbation or which
methods to use for perturbing metabolism to achieve a desired outcome. Therefore,
approaches involving both random mutagenesis and targeted metabolic engineering
are often used for solving different optimization challenges, particularly within the
biotechnology industry (1). The harshness of the mutagenesis conditions dictates the
mutation frequency, and the objective is often to achieve the highest possible mutation
frequency in order to facilitate screening for mutants with the desired traits. A trade-off
is the introduction of numerous other mutations, some of which might affect overall
ﬁtness (2). When using a milder form of mutagenesis, the reduced mutation frequency
necessitates a more efﬁcient screening approach. As an illustration of this problem, tens
of thousands of conventional 96-well microplates are required to select a mutant
bearing a speciﬁc point mutation from a UV-mutagenized Escherichia coli library, where
the mutation frequency is 106 (3). The screening volume has been reduced to 1 l
using higher-throughput microplates with 1,536 wells, but evaporation and the capil-
lary effect often become prohibitive factors (4). In practice, robotics is also required to
be able to perform high-throughput screening (HTS) using microplates, but a generally
low operating rate is a major limitation (5).
Droplet-based microﬂuidics (DBM) has become an attractive alternative to plates
and robotics for HTS, as the reaction mixture volumes are very small and droplets are
sorted at high speed (6). Generally, cells are captured in a surfactant-stabilized aqueous
sphere surrounded by an immiscible oil phase. In contrast to bulk-based ﬂuorescence-
activated cell sorting (FACS), cells freely proliferate and accumulate extracellular prod-
ucts in an isolated compartment, and the droplets are individually screened for their
contents using different approaches (7). The small size of the droplets, whose volumes
are measured in nanoliters or picoliters, allows affordable HTS with much reduced costs
for consumables (8). DBM has been used in several screening applications, such as
optimization of cell factories for the production of both recombinant proteins and
chemicals (6, 7, 9–11). Some studies have also applied this technique to screen libraries
generated using whole-genome random mutagenesis (10, 11). For example, Huang et
al. (10) used droplet sorting to identify yeast mutants from a UV-mutagenized library
that more efﬁciently secreted amylase. Their genome resequencing results reveal that
a total of 330 mutations (approximately 30 mutations/million base pairs [Mbp]) had
accumulated in the mutant, where only a few mutations have been found tightly
correlated to the observed changes in protein secretion. It is also possible to use a mild
mutagenesis strategy that introduces a few variations in the chromosome, which is a
more demanding application requiring a higher-throughput screening. Thus, the ques-
tion of whether the microﬂuidic screening approach is suitable for this challenge has
not yet been completely addressed.
On the other hand, metabolic engineering is often not an option for improving the
microorganisms used within food-related industries, e.g., the dairy and brewing indus-
tries, due to regulations and consumer resistance that prevent the use of genetically
modiﬁed organisms (GMO) in food products (12). In this case, traditional whole-genome
random mutagenesis followed by screening and selection is still the preferred method
for optimizing performance. A good example is lactic acid bacteria (LAB), which are
used extensively within the dairy industry for the manufacture of fermented milk
products (5).
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In milk fermentation, LAB produce lactic acid and other aroma compounds contrib-
uting to taste and ﬂavor formation in the ﬁnished products. In addition, they are able
to change the levels of certain micronutrients in fermented milk through relevant
metabolic activities (13). An example is riboﬂavin, a B group vitamin, which is used both
as a supplement for food and as a natural food color (E-101) (13). This essential vitamin
is ingested by humans through their daily diets, but deﬁciency (ariboﬂavinosis) is still
a common phenomenon in both developed and developing countries and causes
several symptoms, such as hyperemia and cheilosis (13). The use of chemical selection
to obtain non-GMO riboﬂavin overproducers from LAB, e.g., for use in the fortiﬁcation
of fermented food, has been a popular approach that has been used for many years,
but further improvement is limited by a lack of efﬁcient screening tools (13, 14). Here,
we overcome this limitation by implementing DBM to screen a mildly mutagenized
library of the lactic acid bacterium Lactococcus lactis for candidates with improved
riboﬂavin production.
RESULTS
Generation of a riboﬂavin overproducer using roseoﬂavin selection. L. lactis
normally does not accumulate riboﬂavin extracellularly due to the strict regulation of its
biosynthesis, which is mediated by a ﬂavin mononucleotide (FMN) riboswitch. However,
deregulated mutants are easily isolated by selecting for resistance toward the riboﬂavin
analogue roseoﬂavin (14). We used this approach and successfully isolated the mutant
strain JC017, which produced small amounts of riboﬂavin (0.82 mg/liter) when grown
in synthetic medium containing 0.5% glucose. The DNA sequencing results indicated
that the mutant lacked a small chromosomal region (reference position, 1504499 to
1504614) harboring the FMN riboswitch that precedes the riboﬂavin biosynthesis
cluster (15).
Random mutagenesis of the roseoﬂavin-resistant mutant and microﬂuidic
screening. The roseoﬂavin-resistant mutants, in which the FMN riboswitch has been
mutated, show minor increases in the amounts of riboﬂavin they produce (14). We
attempted to further improve the obtained mutant using random mutagenesis fol-
lowed by HTS with the DBM system according to the workﬂow shown in Fig. 1. First, a
1-ml culture of JC017 cells (109 cells) was exposed to the chemical mutagen ethyl
methanesulfonate (EMS), which resulted in a library in which 1% of the original
population survived (Fig. 1, step A). The surviving cells were thoroughly washed and
allowed to recover in GM17 medium overnight (1:100 dilution). The library was then
transferred to synthetic medium before encapsulation of single cells in aqueous
droplets in oil using the microﬂuidics system (Fig. 1, step M1). The cell density in the
aqueous phase was set to approximately 107 cells/ml, resulting in approximately 0.5
cells per 50-pl-sized droplet upon encapsulation. According to the Poisson distribution,
when   0.5, 60% of droplets are empty, 30% of droplets contain 1 cell, and the rest
contain more than 1 cell (16). Droplets were generated at approximately 1 kHz using a
droplet generator (Fig. 1, step M1). Approximately 2  106 droplets were collected in
a syringe (Fig. 1, step M2). After a 24-h incubation, the droplet-containing emulsion was
reinjected into the microﬂuidic sorting device. Mutants were screened for the presence
of riboﬂavin based on its natural ﬂuorescence upon exposure to blue light (excitation
at 490 nm and emission at 510 nm) (Fig. 1, step M3). The sorting was performed at
approximately 0.3 kHz, and a session shorter than 30 min could sort approximately
105 cell-containing droplets. Approximately 50 droplets with the highest levels of
ﬂuorescence (in arbitrary units [AU]) were collected, which corresponded to a cutoff of
0.05% (see Fig. S1 in the supplemental material). The L. lactis cells in the collected
droplets were subsequently released from the emulsions and plated on solid GM17
medium to form single colonies (Fig. 1, step M4). Characterization of 90 of the randomly
picked colonies that grew in a 96-well microplate (Fig. 1, step D) revealed that one-third
of the candidates produced more than 1.5-fold-higher riboﬂavin titers (as evaluated
from the AU on the plate reader) than the parent strain, JC017 (Fig. 2). Six of the
riboﬂavin-overproducing isolates (AH3, AG4, AE6, AF1, AG3, and AH9) were further
Microﬂuidic Screening of Vitamin-Secreting Bacteria ®
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examined in tube fermentation using riboﬂavin-free synthetic medium, and high-
pressure liquid chromatography (HPLC) analysis revealed that all the isolates produced
at least 30% more riboﬂavin in the supernatant than the original roseoﬂavin-resistant
mutant, JC017 (0.82 mg/liter) (Fig. S2). The highest riboﬂavin titer, 2.08 mg/liter, was
observed for isolate AH9 (Fig. S2). The procedure, including mutagenesis and droplet
screening for improving riboﬂavin secretion, was repeated using AH9, and 40% of the
isolates enriched in this screening round produced 1.5-fold more riboﬂavin than AH9
(Fig. 2). The best candidate, BE1, accumulated approximately 4 mg/liter riboﬂavin in the
supernatant (Fig. S2), which was 4-fold higher than the amount of riboﬂavin secreted
by JC017.
Whole-genome resequencing of the riboﬂavin overproducers AH9 and BE1.
The genomes of the two successively isolated strains AH9 and BE1 were resequenced
FIG 1 Incorporation of the droplet-based microﬂuidic screening toolbox into the classical strain development process
based on randommutagenesis and microplate screening. Steps A to G represent the classical protocol, and the microﬂuidic
toolbox (M1 to M5) is inserted between steps A and D. (A) Mutagenesis is induced by physical and chemical mutagens,
such as UV and EMS. Mutation frequency is controlled by either the dosage used or the reaction time. (B) Prior to being
selected by robots, well-separated colonies should have formed on agar plates. (C) Assuming that the automatic selection
and transfer rate is 40 clones/minute (5), the process is completed in approximately 40 h for a library containing 100,000
clones. (D) One thousand 96-well microplates are required in the protocol that does not use the microﬂuidic toolbox. (M1
and M3) notably, if a Poisson distribution  of 0.5 (60% empty droplets) is applied, the true rates for the generation and
sorting of cell-loaded droplets are 60% lower. (M2) The conditions for incubation are the same as in steps B and M4. In this
study, a 24-h incubation at 30°C is typically required for L. lactis. (M4) Cells in droplets are released by the addition of PFOH
(1H,1H,2H,2H-perﬂuorooctan-1-ol). (M5) Due to the efﬁcient enrichment (2,000-fold) using microﬂuidic screening, fewer
than 90 clones are selected for the secondary screening in 96-well microplates.
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to pinpoint the mutations responsible for the improved riboﬂavin production and to
estimate the mutation rate. Sequencing revealed three single-nucleotide variants
(SNVs) and one deletion (52-nt deleted segment, reference position 958508 to 958559
[15]) in AH9 and an additional three SNVs and one indel (insertion/deletion) in BE1
(Fig. 3; Table S1). Consistent with the known effect of the EMS mutagen (17), all SNVs
were G·C-to-A·T variants (Table S1). Most mutations were located in genes with un-
known functions, and none were observed in the riboﬂavin biosynthesis cluster rib-
ABGH or its ﬂanking regions.
The intergenic region preceding the purH gene, which encodes a 5-aminoimidazole-
4-carboxamide ribonucleotide (AICAR) transformylase that catalyzes the second step in
purine de novo synthesis, had been deleted in AH9 (Fig. 3). The missing segment
contains a PurBox regulatory sequence, which is known to be involved in the tran-
scriptional activation of purH (18). In BE1, a mutation (G-to-A transition, reference
position 957859 [15]) was identiﬁed in another PurBox regulatory sequence preceding
the hprT gene, which also forms an operon with purH (Fig. 3) (18).
The wild-type and mutated regions upstream from purH and hprT-purH were fused to
the reporter gene gusA, which encodes -glucuronidase, and were integrated into the
chromosome of the wild-type background (L. lactis MG1363) to determine the effects of
the two mutations on expression. The results of a -glucuronidase assay indicated that the
mutations resulted in reduced expression. The mutation preceding hprT resulted in 3-fold-
lower expression, and the deletion of the second PurBox reduced expression from the
promoter upstream from purH to undetectable levels (Fig. S3).
Identiﬁcation of triggers for riboﬂavin overproduction. Purine de novo biosyn-
thesis provides the precursor GTP for riboﬂavin biosynthesis, and more importantly,
purine nucleotides are essential for energy metabolism and various anabolic processes,
such as DNA, RNA, and protein synthesis. We observed a link between riboﬂavin
production and growth rates for the different mutants, as the speciﬁc growth rate
decreased while riboﬂavin production increased (Fig. 4A). Since the expression of
FIG 2 Secondary screening of riboﬂavin overproducers. Secondary screening of riboﬂavin production by
the captured library was performed in 96-well plates using ﬂuorometric assays. The parent strain JC017
and the mutant strain AH9 (blue-ﬁlled circles) were selected as the basal strains for the two rounds of
mutagenesis and microﬂuidic screening. The relative titers of riboﬂavin are depicted in arbitrary units
(a.u.). A few representative strains (red-ﬁlled circles) were selected for further characterization in test
tubes, and their true riboﬂavin titers were determined using HPLC analysis (see Fig. S2 in the supple-
mental material).
Microﬂuidic Screening of Vitamin-Secreting Bacteria ®
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purine biosynthesis genes was reduced in AH9 and BE1, we decided to test whether
supplementation with purines (200 mg/liter guanosine) would inﬂuence the growth
and riboﬂavin secretion of the original roseoﬂavin-resistant strain JC017 and the DBM
isolates AH9 and BE1. Supplementation indeed resulted in fast growth and similar
growth rates for all three strains, and riboﬂavin production by the isolates AH9 and BE1
decreased to levels comparable to that of the parent strain JC017 (Fig. 4A).
As a simple test to determine whether riboﬂavin overproduction was solely a
consequence of slow growth or whether other factors were involved, we decided to
reduce the growth rate of the parent strain JC017 by adding low concentrations of
chloramphenicol or tetracycline, an approach that has commonly been used to study
FIG 4 Effects of purine metabolism and growth rate on riboﬂavin production. (A) Effects of purine metabolism and growth rate on riboﬂavin yield. Ter,
tetracycline; Cam, chloramphenicol. (B) Effect of inhibiting anabolism on the expression of the riboﬂavin synthesis cluster in the parent strain JC017. The data
are the average results and standard deviations from two independent experiments. Error bars show standard deviations.
FIG 3 Distribution of variations in the mutants. The dashed and lined circles represent the chromosomes
of the mutants AH9 and BE1, respectively. The locations of the mutations identiﬁed in AH9 are labeled
with red-ﬁlled circles. The additional mutations identiﬁed in BE1 compared to AH9 are labeled with
green-ﬁlled circles. A detailed list of mutations is presented in Table S1 in the supplemental material. The
purH gene is transcribed either from its own promoter or through an operon with hprT.
Chen et al. ®
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growth-related effects (19). However, compared to the effects of the mutations, reduc-
ing the growth rate by adding antibiotics had only a moderate effect on riboﬂavin
overproduction in JC017 (Fig. 4A).
We then determined the expression of the riboﬂavin biosynthesis cluster ribABGH in
both the parent strain JC017 and the mutant strain BE1 by fusing its promoter with
gusA. The -glucuronidase activities indicated that ribABGH expression was increased
6-fold in BE1 compared with that in JC017, and the addition of guanosine (200 mg/liter)
restored the ribABGH expression in BE1 to the levels observed in JC017 (Fig. 5; Fig. S3).
The antibiotic-induced reduction in the growth rate did not alter the ribABGH expres-
sion in JC017 (Fig. 4B), although a slight increase in the riboﬂavin titer was observed.
Optimization of riboﬂavin production during fermentation and riboﬂavin bio-
fortiﬁcation in milk. Although purine starvation induced riboﬂavin overproduction in
the mutants, the starvation also signiﬁcantly inhibited growth, which, in principle, has
a negative effect on volumetric productivity and strain stability. We decided to add
small amounts of guanosine to the fermentation broth to achieve a two-stage fermen-
tation, where rapid growth is observed in the ﬁrst phase to ensure the rapid accumu-
lation of biomass, followed by a production phase characterized by slow growth due to
guanosine depletion. The approach was successful (Fig. S4), and the DBM isolate BE1
generated 6.5 mg/liter riboﬂavin, with a higher volumetric productivity than in the
fermentation without the initial purine addition.
The mutants were isolated from a synthetic medium with a composition that is quite
different from that of milk. Due to their non-GMO nature (2, 12), the isolated mutants could
be used to produce fermented foods fortiﬁed with riboﬂavin. Therefore, we decided to test
their performance inmilk. Single colonies of the wild-type (L. lactisMG1363), the parent (the
original roseoﬂavin-resistant mutant derived from L. lactis MG1363, JC017) and the BE1
strains were inoculated into 50 ml of milk. After a 24-h incubation, all growth had ceased
due to acidiﬁcation of the milk, and the riboﬂavin content was determined. The wild-type
strain reduced the natural riboﬂavin content of the milk from 0.99 mg/liter to 0.66 mg/liter
(Fig. 6); however, both the parent strain and the BE1 strain increased the riboﬂavin content,
to 1.51 mg/liter and 2.81 mg/liter, respectively.
DISCUSSION
With a lack of prior knowledge regarding how to alter a phenotypic property of
microorganisms, classic random mutagenesis followed by screening for mutants of
interest has been extensively used for this purpose, and in combination with reverse
engineering, the underlying determinants could be clariﬁed (4). In contrast, metabolic
engineering is a more targeted approach that has been used extensively to optimize
cell factories when prior knowledge of metabolic pathways is available; however,
FIG 5 Pleiotropic effects of the purH-related mutations on riboﬂavin synthesis and anabolism. The line
widths of the arrows (green and brown) represent the relative expression levels of purH and ribABGH.
Differences in anabolism are indicated by the relative growth rates. The data presented for purH were
summed from the results for purH and the hprT-purH fusion. Detailed expression data are presented in
Fig. S3 in the supplemental material.  purine, 200 mg/liter guanosine was added; PRPP, phosphoribosyl
pyrophosphate; AICAR, 5-aminoimidazole-4-carboxamide ribonucleotide; FAICAR, 5-formamidoimidazole-4-
carboxamide ribotide.
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the genes that need to be mutated are not always obvious (20). In our study, the
objective was to improve riboﬂavin production; thus, one would assume that a suc-
cessful strategy would involve strengthening the metabolic ﬂux toward GTP, which is
an essential riboﬂavin precursor (21). Very unexpectedly, the mutants generated by
mutagenesis showed the opposite result, as impairment in purine biosynthesis in the
mutants triggered the riboﬂavin overproduction (Fig. 3 and 4).
Purine biosynthesis provides the vital building blocks required for the synthesis of
DNA, RNA, the energy carriers involved in metabolism (ATP and GTP), and molecules
involved in cellular signaling, such as cyclic AMP (cAMP), cGMP, and ppGpp (22). When
the cultures were not supplemented with purines, the mutants grew more slowly
due to the mutations in the genes involved in purine metabolism (Fig. 4A). Thus, we
artiﬁcially inhibited the growth of the parent strain JC017 by adding antibiotics
targeting protein synthesis to test whether slow growth explained the increased
riboﬂavin production. Indeed, the riboﬂavin production was increased in JC017, but
only slightly. Slow growth has been shown to promote the production of vitamins
derived from GTP, and this effect is due to a surplus of GTP from the reduced anabolism
for vitamin biosynthesis under these circumstances (19). In our case, the slow growth
of the mutants was a direct consequence of purine starvation (Fig. 4A and 5), indicating
that other factors in addition to a slow anabolism are involved. In the microorganisms
that naturally produce riboﬂavin, such as some fungi, the expression of riboﬂavin
biosynthesis genes is normally induced during the transition from the vegetative phase
to the stationary phase, and here, the growth rate is the trigger (23). However, when we
inhibited the growth of the original roseoﬂavin-resistant mutant JC017 by adding
tetracycline, the expression of the riboﬂavin operon was not affected (Fig. 4B).
For the mutant BE1, the expression of the riboﬂavin operon was increased 6-fold
compared to its expression in JC017, but only in the absence of purine nucleosides
(Fig. 5; see also Fig. S3 in the supplemental material). In bacteria, riboﬂavin biosynthesis
is normally tightly controlled by an FMN riboswitch. This riboswitch had been elimi-
nated in the original roseoﬂavin-resistant mutant JC017, but the repressive effect of
guanosine indicates that other regulatory mechanisms are active. Riboﬂavin production
in Ashbya gossypii is activated by sporulation, which is negatively regulated by purine
derivatives, such as cAMP (24). Further investigation is required to determine whether
the effects observed in the L. lactis mutants are mediated by cAMP or other purine
derivatives.
In a random mutagenesis experiment, it is difﬁcult to achieve a sufﬁciently high
FIG 6 Riboﬂavin content of milk after fermentation by different strains. WT, L. lactis MG1363; RFMT, the
parent strain JC017 derived from MG1363 by roseoﬂavin selection. The data are the averages and standard
deviations from three biologically independent replications. Error bars show standard deviations.
Chen et al. ®
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mutation rate to facilitate selection of the relevant phenotype, since the chances of
introducing other unwanted mutations are also concomitantly increased (25). Un-
wanted mutations may have deleterious effects on bacterial ﬁtness, and Maisnier-Patin
et al. have estimated that the presence of 50 nontarget mutations per genome in
bacteria results in an approximately 40% average decrease in the growth rate, whereas
the presence of 5 nontarget mutations reduced this value to 10% (26). According to a
study by Kibota and Lynch, 10% of spontaneous mutations arising during evolution
have a negative effect on bacterial ﬁtness (27). This effect may be exacerbated in an
industrial setting, where microorganisms must cope with large ﬂuctuations in nutrient
availability and temperature and are exposed to various stresses (28). Moreover, certain
ﬁtness-irrelevant metabolic traits, such as the ability to form certain fermentation
products, e.g., acids, ﬂavors, and compounds contributing to texture, must be consid-
ered when evaluating microorganisms applied in food fermentation (29). Thus, the
number of unwanted mutations is preferred to be minimized.
Often, only a few of the mutations introduced by random mutagenesis are actually
linked to the desired property, and unwanted mutations constitute the major fraction
of the identiﬁed mutations, particularly when a high dose of mutagen has been applied
to facilitate selection (10, 20). Therefore, the use of a milder mutagenesis approach is
preferred, and researchers can compensate for the reduced frequency with efﬁcient
screening approaches. In the current study, we used a DBM system to achieve this goal.
The mutants obtained using the DBM system were veriﬁed using the low-throughput
equipment (96-well plates with plate reader), which was manageable due to the
efﬁcient primary enrichment using droplet sorting, which resulted in a large fraction (30
to 40%) of true riboﬂavin overproducers (Fig. 2), which were further veriﬁed using HPLC
analysis (Fig. S2). Moreover, the stable mutation rate (Fig. 3) and high fraction of true
riboﬂavin overproducers that resulted from droplet sorting (Fig. 2) in the iterative
rounds of the mutagenesis screen showed that the entire procedure was easily con-
trollable and highly efﬁcient. In this study, the total operating time required for one
round of droplet generation and sorting was less than 1 h (Fig. 1, steps M1 and M3).
Using an automated liquid handling system for the same task on 96-well microplates
would require more than one day for colony selection and more substantial loads
to read the plates (Fig. 1, steps C and D). Although additional incubation steps are
required between droplet generation and sorting when using the DBM system (Fig. 1,
step M2), the efﬁcient enrichment (2,000 times) with DBM screening also signiﬁcantly
reduced the expenditures for consumables. Using this paradigm, one thousand 96-well
microplates and more consumables for colony picking and culturing (6) would be used
for the same project if the classical strain development procedure was followed (Fig. 1).
The efﬁciency of the DBM screening system allowed us to easily capture mutants with
the desired phenotype, and the low mutation rate allowed us to easily link the mutation to
the phenotype. In principle, the approach using mild random mutagenesis in combination
with DBM screening can be applied to all types of cells. In particular, this approach would
be useful for prokaryotes, which generally possess smaller genomes, as genome sequenc-
ing and reverse engineering are quite simple, thus avoiding complicated systematic
approaches (10, 20). In this study, we took advantage of the natural ﬂuorescence of
riboﬂavin for detection, but other approaches can easily be used as well. The recent
development of GFP-based biosensor technology has been successfully applied to isolate
microorganisms producing riboﬂavin and other compounds (9, 30).
Compartmentalization in water-in-oil droplets sequesters individual bacterial cells in
an emulsion bulk, and thus, the performance of individual cells in producing chemicals
and proteins is traceable. Although FACS-based screening can be performed a thou-
sand times faster than DBM screening, the lack of compartmentalization does not
provide FACS with the capacity to perform the same tasks (31). Recently, the emer-
gence of double-layer droplet technology (a water-in-oil-in-water emulsion) has al-
lowed researchers to accommodate the sorting of droplets on a commercial FACS
machine, which has been shown to be 10 times faster than screening on a
microﬂuidics-based sorter (8, 32). Nevertheless, there are still several limitations to
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sorting double-layer droplets in FACS for the purpose of screening. First, the small size
of the nozzle used in a common FACS setup does not readily accommodate the large
droplets that are normally used to propagate microbes and accumulate extracellular
metabolites (7, 8, 11). The size of double-layer droplets is reduced by a hypertonic
solution as they pass through the nozzle, but the concomitant osmotic stress will have
detrimental effects on bacterial ﬁtness, potentially affecting further recovery (8). Sec-
ond, further modiﬁcations of contents, such as droplet merging after encapsulation, are
restricted in double-layer droplets (31), which may be important if cell growth and
analysis are performed in a two-step manner (7).
In summary, DBM is a powerful tool for isolating useful riboﬂavin-producing L. lactis
variants. In principle, the tool can be used on any cell type to examine other properties,
and DBM is perfectly suited for optimizing industrially used cell factories or microor-
ganisms used for food fermentation due to its highly efﬁcient sorting process. Based on
our results showing that large populations can be screened rapidly, harsh mutagenesis
is no longer required to obtain a desired phenotype.
MATERIALS AND METHODS
Bacterial strains and culture medium. The L. lactis strains used in this study are listed in Table S2
in the supplemental material. M17 broth (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 0.5%
glucose (GM17 broth) was used for the general cultivation of the L. lactis strain. Nucleoside- and
riboﬂavin-free SA medium supplemented with 0.5% glucose and 15 mM acetate instead of lipoic acid
was used for the isolation and assessment of riboﬂavin overproducers (33). When necessary, guanosine
was supplied to the SA medium at a concentration of 5 mg/liter or 200 mg/liter. The Escherichia coli
strains used for cloning were grown aerobically in Luria-Bertani (LB) broth (34). Different antibiotics were
used to maintain the plasmids in the strains. Erythromycin concentrations of 150 g/ml and 5 g/ml
were used for the E. coli and L. lactis strains, respectively. A chloramphenicol concentration of 5 g/ml
was used for L. lactis. For testing riboﬂavin fortiﬁcation in milk, the L. lactis strains derived from L. lactis
MG1363 were transformed with plasmid pLB712 prior to milk fermentation (35). Ultrahigh-temperature-
processed (UHT) whole milk (Arla Food A.m.b.a, Viby J, Denmark) was used for testing riboﬂavin
production in milk by different strains.
Isolation of the roseoﬂavin-resistant mutant. A previously described procedure (14) was used to
isolate the roseoﬂavin-resistant mutant on riboﬂavin-free SA agar plates containing 100 mg/liter roseo-
ﬂavin (MP Biomedicals, Santa Ana, CA, USA).
Fabrication of microﬂuidic devices. The two chips used for the encapsulation and sorting of the
droplets are both composed of a structured polydimethylsiloxane (PDMS) slab bonded to a glass slide.
A 10:1 (wt/wt) mixture of PDMS (Sylgard 184; Dow Corning, Auburn, MI, USA) was cast over a mold
created using regular UV photolithography to pattern a layer of SU-8 2075 epoxy resist (MicroChem,
Westborough, MA, USA) on a 4-inch silicon wafer. The PDMS was cured overnight at 60°C, cut into
separate devices, and carefully removed from the mold. Holes for inlets and outlets were created using
biopsy punches (Ø:0.75 mm). Both the glass slides and PDMS parts were exposed to 50-W, 13.56-MHz air
plasma for 60 s (Atto plasma cleaner; Diener, Ebhausen, Germany) and then immediately bonded, placed
under a weight (400 g/slide), and incubated at 90°C for 10 min. After cooling, the channels were ﬂushed
with ﬁltered Aquapel and subsequently quickly purged by applying a vacuum to the outlets. The sorting
chips were heated on an 85°C hotplate, allowing a low-temperature solder wire (Indalloy number 19;
Indium Corp., Clinton, NY, USA) to be inserted and ﬁll the electrode cavities. Before cooling the device,
small pieces of wire were inserted as connectors to the electrodes.
Experimental setup of microﬂuidic devices. The microﬂuidic setup was inspired by the system
described by Mazutis et al. (16). The sorting chip was placed on a custom-built ﬂuorescence microscope,
where a 488-nm laser (06-01; Cobolt, Solna, Sweden) was guided through a 1,000-mm cylindrical lens
(LJ1516RM-A; Thorlabs, Newton, NJ, USA) and a 10 microscope objective (N10X-PF; Thorlabs) to form
a narrow line for ﬂuorescence detection. The ﬂuorescent light emitted was transmitted through a
dichroic mirror (MD499; Thorlabs) and a bandpass ﬁlter (MF530-43; Thorlabs) before being measured by
a photomultiplier tube (PMT) (PMTSS; Thorlabs). A ﬁeld-programmable gate array (FPGA) (PCIe-7842R;
National Instruments, Austin, USA) was programmed to sample the PMT signal every 7 s (143 kHz) and
continuously evaluate both the signal width and intensity. When a signal fell within the preset gating,
the on-chip electrodes were activated with a square voltage wave (15 kHz) ampliﬁed to 400 V (Trek
623B; Trek, Inc., Lockport, NY, USA). The ﬂuidic inlets were connected to a vertically oriented syringe
pump (PHD 2000; Harvard Apparatus, Inc., Holliston, MA, USA) using PTFE tubing (TW30; Adtech, Stroud,
United Kingdom) with an internal diameter of 320 m. Fluorinated ethylene propylene (FEP) tubing
(JR-T-6794-M10; VICI-Jour, Schekon, Switzerland) with an inner diameter of 100 m was used for the
ﬂuidic outlets to ensure that the sorted drops were immediately pushed out of the tubing and collected
in Eppendorf tubes.
Chemical mutagenesis. L. lactis strains were grown in GM17 broth overnight at 30°C to achieve a
density of 109 cells/ml. Mutagenesis was conducted by adding 3% ethyl methanesulfonate (EMS; Sigma,
St. Louis, MO, USA) to the overnight culture, followed by a 3-h incubation at 30°C. Samples were then
washed twice with fresh GM17 to remove the residual EMS. Afterward, samples were used for further
Chen et al. ®
May/June 2017 Volume 8 Issue 3 e00526-17 mbio.asm.org 10
 
m
bio.asm
.org
 o
n
 June 14, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
experiments or frozen in 20% glycerol at 80°C. For determining the survival rate, the EMS-treated/
untreated samples were plated on GM17 agar plates with appropriate dilutions. After a 48-h incubation
at 30°C, the colonies were counted to estimate the survival rate.
Encapsulation in droplets. The library was ﬁrst diluted into SA medium at a density of 107 cells/ml.
Both the aqueous (culture) and oil (Dolomite Pico-Surf 2, 5%; Royston, United Kingdom) inﬂow rates were
set to 10 l/min, which normally resulted in a droplet size of 50 pl. A 1-ml syringe (BD Medical, Sandy,
UT, USA) was connected to the outlet to collect the emulsions. After incubation, the fraction of
cell-loaded droplets was estimated by examining the monodisperse emulsions on a microscope.
Fluorescence-based sorting. After incubation, samples in syringes were reinjected into the sorting
chip at a rate of 1 l/min, and the continuous phase of the Novec 7500 (3M, St. Paul, MN, USA) was set
to 10 l/min to allow sufﬁcient space between two adjacent droplets. The ﬂuorescence intensity of each
drop was measured and compared to a preset gating level. For each sorting operation, the electrical ﬁeld
was triggered for 1,750 s after a 250-s delay to allow droplets to pass the gap between the laser spot
and the electrodes. Samples were collected directly from the outlet channels into a 1.5-ml Eppendorf
tube containing 300 l of phosphate-buffered saline (PBS) buffer (pH 7.4).
Release of cells from droplets. Samples obtained from sorting were ﬁrst centrifuged at 100  g for
30 s to ensure that the emulsions were ﬂoating in the layer between the oil and aqueous phases. After
removing as much of the bottom layer (oil phase) as possible by pipetting, 300 l of PFOH (1H,1H,2H,2H-
perﬂuorooctan-1-ol) (Sigma, St. Louis, MO, USA) was added to disrupt the droplets and release the cells
into the aqueous layer. The aqueous phase containing the cells was spread directly onto GM17 agar
plates at an appropriate dilution and incubated.
Genome resequencing and mutation identiﬁcation. Genomic DNA was puriﬁed from the mutant
using a DNeasy blood and tissue kit (Qiagen, Hilden, Germany), and the quality was assessed using DNA
electrophoresis and a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientiﬁc, Waltham, MA, USA).
Genome sequencing was performed by Macrogen (Seoul, South Korea). Brieﬂy, 2 g of genomic DNA
was randomly sheared using a nebulizer (Illumina, San Diego, CA, USA), and the ends were repaired using
polynucleotide kinase (Illumina) and Klenow enzyme (Illumina). The 5= ends of the DNA fragments were
phosphorylated, and a single adenine base was added to the 3= ends using Klenow exo (Illumina).
Following the ligation of a pair of Illumina adaptors to the repaired ends, the DNA was ampliﬁed in 10
cycles using adaptor primers (Illumina), and fragments of approximately 150 bp were isolated using
agarose gel electrophoresis. Sequencing libraries were quantiﬁed with a 2100 BioAnalyzer DNA 1000 chip
(Agilent, Santa Clara, CA, USA), as well as the PicoGreen ﬂuorescence assay (Invitrogen, Carlsbad, CA,
USA). Clusters were generated on an Illumina cluster station (Illumina) using 11 pmol of sequencing
libraries. Thirty-eight sequencing cycles were performed using the Illumina Genome Analyzer IIx system
(Illumina) according to the manufacturer’s speciﬁcations. CLC Genomics Workbench (Qiagen, Hilden,
Germany) was used to map the reads, detect single-nucleotide variations (SNVs) and insertion/deletion
events (INDELs), and identify genomic rearrangements using the published genomic sequence of L. lactis
MG1363 as the reference (15).
Quantiﬁcation of riboﬂavin secretion. The extracellular riboﬂavin concentration was determined
using reversed-phase HPLC. A Bondapak C18 column (Waters Associates, Milford, USA) was used, and
the mobile phase consisted of water-methanol-acetic acid (68:32:0.1 [vol/vol]). Detection was performed
using UV spectroscopy at 270 nm. Samples were pretreated using a previously described acetic acid
extraction procedure prior to analysis of the riboﬂavin content in milk (36).
-Glucuronidase activity assay. The fragments containing promoters and 5= untranslated regions,
including the Shine-Dalgarno sequence, were PCR ampliﬁed using the primers listed in Table S3 to
construct the strains for the -glucuronidase assay. These PCR fragments were cloned into the XbaI site
of the pLB85 vector (37) using Gibson assembly (38). The constructs were integrated into the attB site in
the chromosome of the L. lactis strain bearing the pLB65 vector that expresses the TP901-1 integrase (37).
The activity of the -glucuronidase enzyme was assessed using para-nitro--glucuronic acid (PNPG)
(Sigma, St. Louis, MO, USA) as the substrate according to a previously described procedure (39).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00526-17.
FIG S1, TIF ﬁle, 0.4 MB.
FIG S2, TIF ﬁle, 0.1 MB.
FIG S3, TIF ﬁle, 0.3 MB.
FIG S4, TIF ﬁle, 0.1 MB.
TABLE S1, DOCX ﬁle, 0.1 MB.
TABLE S2, DOCX ﬁle, 0.04 MB.
TABLE S3, DOCX ﬁle, 0.05 MB.
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